Rational, High Quality Laboratory Monitoring before, during, and after Infusion of Prothrombin Complex Concentrates
- 17 August 1999
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 95 (4) , S25-S30
- https://doi.org/10.1016/s0049-3848(99)00081-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Determinants of plasma factor VIIa levels in humansBlood, 1995
- High-Purity Factor IX Concentrates for Treatment of Hemophilia B: Relative Purity and Thrombogenic PotentialActa Haematologica, 1995
- Ischemic venous thrombosis caused by a distinct disturbance of the extrinsic clotting systemJournal of the American Academy of Dermatology, 1993
- Congenital Bleeding DisordersDrugs, 1993
- Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activationBlood, 1993
- Measurement of basal levels of factor VIIa in hemophilia A and B patients [see comments]Blood, 1992
- No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrateBritish Journal of Haematology, 1991
- Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrateBlood, 1990
- Comparison of different prothrombin complex concentrates - in vitro and in vivo studiesThrombosis Research, 1990
- PROTHROMBIN COMPLEX CONCENTRATES: CLINICAL USE*Annals of the New York Academy of Sciences, 1981